| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |